Sandoz recalls birth control pills; insurer denies Teva claim for settlement;

 @FiercePharma:  FDA to update generic labeling rules. Article | Follow @FiercePharma

 @CarlyHFierce: ICYMI: Glass particles trigger another Fresenius Kabi recall. Story | Follow @CarlyHFierce

> Sandoz is recalling one lot of Estarylla birth control pills after receiving a report that one of the placebo pills was in the row of pills that should have contained active ingredients. Release

> Illinois Union Insurance has filed suit against Teva Pharmaceutical Industries ($TEVA) saying it should not have to cover a portion of Teva's $1.6 billion patent infringement settlement with Pfizer ($PFE) over the acid-reflux drug Protonix. Story

> The branded melanoma market is projected to climb to more than $2.8 billion across the U.S. and major European markets by 2021 according to a new report. Release

> Impax Laboratories ($IPXL) has named to its board of directors Mary K. Pendergast, a lawyer who specializes in pharmaceutical regulatory issues. Release

> Novartis ($NVS) has filed suit against Intas Pharmaceuticals saying it is seeking to make a copycat version of its immunosuppressant drug Myfortic before the expiration of Novartis's patents. Story

> A federal judge says that Sunovion Pharmaceuticals has violated Mylan's ($MYL) patents for the bronchitis and emphysema drug Brovana. Story

Medical Device News

 @FierceMedDev: Europe tables vote on tougher device regs. More | Follow @FierceMedDev

 @MarkHFierce:  We want your FMD Fierce 15 nominations. Send them in! More | Follow @MarkHFierce

 @DamianFierce: Theragenics has signed a deal to get its brachytherapy products on the market in the EU. Story | Follow @DamianFierce

 @MichaelGFierce: ICYMI: Avanir drops $110M on novel inhaled-delivery migraine device. Article | Follow @MichaelGFierce

>  India's move to modernize its medical device regulations appears close. More

> U.K. playing catch-up with proton-therapy devices. News

Biotech News

 @FierceBiotech:  SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech

 @JohnCFierce:  Orexo stakes out $500M market for new opioid-addiction drug. More | Follow @JohnCFierce

 @RyanMFierce:  Xoma staffers form biotech startup to advance blood pressure med. News | Follow @RyanMFierce

 @EmilyMFierce:  In case you missed it over the holiday... Scientists create first regulatory map of tuberculosis. Report | Follow @EmilyMFierce

> Scientists score stem-cell victory with lab-grown liver tissue. Story

> Sarepta readies $125M raise to back muscular dystrophy drug work. Item

> Belgian biotech Cardio3 completes modest IPO. More

Vaccines News

> Reliance on NIH threatens HIV vaccine funding. Story

> Polio discovery prompts Israeli vaccination push. More

> Merck KGaA: Lung cancer vaccine not dead. Article

> Study: Use of 2D barcodes could save healthcare $300M. News

> Novartis and Sanofi nab DoD vaccine contracts. Item

And Finally... The European Promotional Product Association (EPPA) is threatening new rules that would limit the promotion gifts that drug sales reps give away to doctors. Story

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.